199 related articles for article (PubMed ID: 29548009)
21. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.
Lu CL; Chuang YC; Chang HC; Chen YC; Wang JT; Chang SC
J Antimicrob Chemother; 2012 Sep; 67(9):2243-9. PubMed ID: 22618861
[TBL] [Abstract][Full Text] [Related]
22. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
24. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
Olivier CN; Blake RK; Steed LL; Salgado CD
Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
[TBL] [Abstract][Full Text] [Related]
25. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.
Nourse C; Murphy H; Byrne C; O'Meara A; Breatnach F; Kaufmann M; Clarke A; Butler K
Eur J Pediatr; 1998 Jan; 157(1):20-7. PubMed ID: 9461358
[TBL] [Abstract][Full Text] [Related]
26. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.
Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
Clin Infect Dis; 2008 Mar; 46(5):678-85. PubMed ID: 18230044
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
Nguyen GC; Leung W; Weizman AV
Inflamm Bowel Dis; 2011 Jun; 17(6):1338-42. PubMed ID: 21560197
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
[TBL] [Abstract][Full Text] [Related]
29. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
Carmeli Y; Samore MH; Huskins C
Arch Intern Med; 1999 Nov; 159(20):2461-8. PubMed ID: 10665895
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
Kaya A; Kaya SY; Balkan II; Bayramlar OF; Mete B; Saltoglu N; Aygün G; Tabak ÖF
Wien Klin Wochenschr; 2021 May; 133(9-10):478-483. PubMed ID: 32910333
[TBL] [Abstract][Full Text] [Related]
31. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
32. Low risk of apparent transmission of vancomycin-resistant Enterococci from bacteraemic patients to hospitalized contacts.
Mutters NT; Brooke RJ; Frank U; Heeg K
Am J Infect Control; 2013 Sep; 41(9):778-81. PubMed ID: 23453393
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: A 10-year study in a tertiary-care centre in Mexico City.
López-Luis BA; Sifuentes-Osornio J; Lambraño-Castillo D; Ortiz-Brizuela E; Ramírez-Fontes A; Tovar-Calderón YE; Leal-Vega FJ; Bobadilla-Del-Valle M; Ponce-de-León A
J Glob Antimicrob Resist; 2021 Mar; 24():198-204. PubMed ID: 33359937
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
Song JY; Cheong HJ; Jo YM; Choi WS; Noh JY; Heo JY; Kim WJ
Am J Infect Control; 2009 Nov; 37(9):734-40. PubMed ID: 19188004
[TBL] [Abstract][Full Text] [Related]
35. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
[TBL] [Abstract][Full Text] [Related]
37. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic.
Timmers GJ; van der Zwet WC; Simoons-Smit IM; Savelkoul PH; Meester HH; Vandenbroucke-Grauls CM; Huijgens PC
Br J Haematol; 2002 Mar; 116(4):826-33. PubMed ID: 11886387
[TBL] [Abstract][Full Text] [Related]
38. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
